Application note: Quantitation of Antibody-Drug Conjugates (Gyros)

Gyros_Logo_RGB-01Antibody-Drug Conjugates (ADCs) represent a novel type of therapeutic that uses the specificity of monoclonal antibodies to target a tumor-specific antigen and deliver a payload of small cytotoxic molecules to the tumor. Using Gyrolab™ xP workstation, a generic IgG assay and an assay to measure payloads of ADCs can be quickly developed in parallel.

Gyrolab xP workstation supports high productivity for ADC development in support of both toxicology (non-GLP) studies and subsequent regulated studies.

Download Application Note Now

Related Links